Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients

Eric Sanchez, BA, Abigail Gillespie, BS, Nika Manik Harutyunyan, George Tang, PhD, Jillian Gottlieb, Suzie Vardanyan, MS, Mingjie Li, BS, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Haiming Chen, MD PhD, James Berenson, MD

Blood (2015) 126 (23): 1799.

https://doi.org/10.1182/blood.V126.23.1799.1799

Published: 2015

Journal Articles

Circulating Bcma Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients

Eric Sanchez, BA, Abigail Gillespie, Nika M Harutyunyan, George Tang, PhD, Jillian Gottlieb, Suzie Vardanyan, MS, Mingjie Li, BS, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Judith Finlay, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2014) 124 (21): 4713.

https://doi.org/10.1182/blood.V124.21.4713.4713

Published: 2014

Journal Articles

Serum B-Cell Maturation Antigen Is a Novel Prognostic Indicator for Multiple Myeloma Patients and Correlates with Clinical Status and Survival

Michael Ghermezi, Suzie Vardanyan, MS, Nika Manik Harutyunyan, Jillian Gottlieb, Ariana Berenson, Claudia Andreu-Vieyra, Eric Sanchez, BA, Regina A. Swift, RN, James R. Berenson, MD

Blood (2014) 124 (21): 3405.

https://doi.org/10.1182/blood.V124.21.3405.3405

Published: 2014

Journal Articles

Lack of Significance of ISS Staging and Depth of Response in Predicting Overall Survival for Multiple Myeloma Patients

Ariana Berenson, Suzie Vardanyan, MS, Michael Ghermezi, Nika M Harutyunyan, Jillian Gottlieb, Ran Halleluyan, Claudia Andreu-Vieyra, Regina A. Swift, RN, James R. Berenson, MD

Blood (2014) 124 (21): 5771.

https://doi.org/10.1182/blood.V124.21.5771.5771

Published: 2014

Journal Articles

Carfilzomib Overcomes Resistance to Bortezomib in the Human Lagk-1A Multiple Myeloma Xenograft Model

Eric Sanchez, BA, Mingjie Li, BS, Abigail Gillespie, Nika M Harutyunyan, Gigi Garzio, Joseph Ben-Zvi, Jillian Gottlieb, George Tang, PhD, Cathy Wang, BS, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2014) 124 (21): 5720.

https://doi.org/10.1182/blood.V124.21.5720.5720

Published: 2014

Journal Articles

Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression-Free Survival for Multiple Myeloma Patients

Nika M Harutyunyan, Suzie Vardanyan, MS, Michael Ghermezi, Jillian Gottlieb, Ariana Berenson, Claudia Andreu-Vieyra, George Tang, PhD, Eric Sanchez, BA, Mingjie Li, BS, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Haiming Chen, MD, PhD, Judith Finlay, PhD, James R Berenson, MD

Blood (2014) 124 (21): 2125.

https://doi.org/10.1182/blood.V124.21.2125.2125

Published: 2014

Journal Articles

Increased M2 Macrophages and Higher Levels Of The Tribble Family Member Trib1 In Monocytes Are Associated With Progressive Disease In Multiple Myeloma (MM) Patients

Haiming Chen, MD., Ph.D, Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Joseph Ben-Zvi, Mitchell Song, Ran Halleluyan, Eric Sanchez, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2013) 122 (21): 3127.

https://doi.org/10.1182/blood.V122.21.3127.3127

Published: 2013

Journal Articles

Carfilzomib Platform Study Using The LAGκ-1A Multiple Myeloma Xenograft Model

Eric Sanchez, Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Kevin Delijani, Joseph Ben-Zvi, Mitchell Song, Ran Halleluyan, Cathy S Wang, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2013) 122 (21): 4452.

https://doi.org/10.1182/blood.V122.21.4452.4452

Published: 2013

Journal Articles

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Mingjie Li, Suzie Vardanyan, Jillian Gottlieb, Cathy Wang, Kevin Delijani, Ran Halleluyan, Joseph Ben-Zvi, Mitchell Song, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2013) 122 (21): 5362.

https://doi.org/10.1182/blood.V122.21.5362.5362

Published: 2013

NARROW

Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients

Circulating Bcma Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients

Serum B-Cell Maturation Antigen Is a Novel Prognostic Indicator for Multiple Myeloma Patients and Correlates with Clinical Status and Survival

Lack of Significance of ISS Staging and Depth of Response in Predicting Overall Survival for Multiple Myeloma Patients

Carfilzomib Overcomes Resistance to Bortezomib in the Human Lagk-1A Multiple Myeloma Xenograft Model

Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression-Free Survival for Multiple Myeloma Patients

Increased M2 Macrophages and Higher Levels Of The Tribble Family Member Trib1 In Monocytes Are Associated With Progressive Disease In Multiple Myeloma (MM) Patients

Carfilzomib Platform Study Using The LAGκ-1A Multiple Myeloma Xenograft Model

Higher TRAF6 and Fbxo 3 Expression Is With Progressive Multiple Myeloma and Blockage Of TRAF6 Inhibits Tumor Growth and Bone Resorption

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only